AXIS Capital (AXS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Reported Q3 2024 net income available to common shareholders of $173 million ($2.04 per diluted share) and operating income of $230 million ($2.71 per diluted share), with annualized ROE of 13% and operating ROACE of 17.3%.
Book value per diluted common share rose to $64.65, up 9% in the quarter and 26.3% year-over-year.
Gross premiums written reached a record $1.9 billion, with insurance segment at $1.5 billion, driven by property, credit & political risk, and A&H lines.
Net investment income hit a record $205 million, up 33% year-over-year, fueled by higher yields and increased fixed maturity assets.
Maintained disciplined underwriting, strong reserves, and operational efficiency despite significant catastrophe losses.
Financial highlights
Combined ratio for Q3 2024 was 93.1%; insurance segment at 90.4%, reinsurance at 91.4%.
G&A expense ratio improved to 12.1% from 13.5% year-over-year.
Total capital returned to shareholders year-to-date was $253 million, including $140 million in share repurchases and $113 million in dividends.
Debt to total capital ratio at 17.8%, with common shareholders' equity at $5.5 billion.
Book value per diluted share increased by $5.36 in the quarter, driven by net income and net unrealized investment gains.
Outlook and guidance
Management remains confident in profitable growth, focusing on specialty underwriting, operational efficiency, and digital transformation.
Insurance gross premiums growth expected at the low end of the 7%-12% range for full-year 2024.
G&A ratio target remains below 11% for full year 2026.
$300 million share repurchase program authorized in May 2024, with $260 million remaining.
Latest events from AXIS Capital
- Record premiums, 18.3% book value growth, and improved combined ratio marked the year.AXS
Q4 20253 Feb 2026 - Q2 net income reached $204M, with record EPS, strong premiums, and improved efficiency.AXS
Q2 20242 Feb 2026 - LPT with Enstar shifts $2.35B in reserves, boosting specialty focus and capital flexibility.AXS
UBS Global Specialty Insurance/Reinsurance Virtual Conference 202411 Jan 2026 - Record 2024 earnings, premium growth, and capital returns with improved profitability.AXS
Q4 20249 Jan 2026 - Orderly CFO transition, selective specialty growth, and data-driven efficiency define the outlook.AXS
KBW Insurance Conference 20255 Jan 2026 - Q1 2025 delivered record EPS, 19.2% ROACE, and strong premium and book value growth.AXS
Q1 202523 Dec 2025 - 2024 saw record growth, strong governance, and expanded ESG, with key votes on directors and pay.AXS
Proxy Filing2 Dec 2025 - Specialty-driven growth, strong governance, and ESG leadership define the 2025 proxy agenda.AXS
Proxy Filing2 Dec 2025 - Director elections, executive pay, and auditor appointment up for vote at the 2025 meeting.AXS
Proxy Filing2 Dec 2025